Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.25M P/E - EPS this Y - Ern Qtrly Grth -
Income -2.09M Forward P/E - EPS next Y - 50D Avg Chg 27.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -36.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -84.00%
Recommedations - Quick Ratio 1.02 Shares Outstanding 169.73M 52W Low Chg 124.00%
Insider Own 40.00% ROA -233.37% Shares Float 93.95M Beta -3.20
Inst Own 0.63% ROE - Shares Shorted/Prior -/- Price 0.07
Gross Margin - Profit Margin - Avg. Volume 305,399 Target Price -
Oper. Margin - Earnings Date Jun 29 Volume 87,000 Change 0.00%
About NASCENT BIOTECH INC

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

NBIO Chatroom

User Image J1983 Posted - 04/30/24

$NBIO Very quiet here…

User Image Gj64 Posted - 04/18/24

$NBIO LMDX

User Image ok2buy Posted - 04/18/24

$NBIO OTCN back on the ask at 10 cents (5000 shares), but it is NITE holding this back, mini wall at 10 cents (50,000 shares) on the ask. We need a P.I.M.P (Person In a Management Position) to hit the ask and buy some shares at market. That would be a huge confidence booster. Best of luck to the longs, SL, the good DR., the lovely Miss Katie, BP and MG./

User Image BlazingStocks Posted - 04/16/24

$NBIO - Management anticipates that some research sites will open for the start of Phase II testing late this summer with actual patients involved later in 2024. https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO Management anticipates that some research sites will open for the start of Phase II testing late this summer with actual patients involved later in 2024. https://feeds.issuerdirect.com/news-release.html?newsid=6862033163147368 @Nascent_BioTech #FDA

User Image BlazingStocks Posted - 04/16/24

$NBIO - Mr. Carrick continued, "Phase I demonstrated an excellent safety profile at various doses. Phase II will be focused on clinical outcomes, and we are taking no shortcuts." https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO Announced today that it is embarking on a fresh manufacturing run to ensure Pritumumab ("PTB") supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial. https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturing run to ensure Pritumumab ("PTB") supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial. "Taking the time to navigate this opportunity with proper care and diligence is a step that demonstrates our commitment to the best interests of our investors, partners, shareholders, and potential future patients," remarked Sean Carrick, CEO of NBIO. "No one likes delays, but patience and care at this critical stage is necessary in maximizing patient outcomes and long-term shareholder value. We want to be careful not to make hasty decisions while exploring all options.

User Image BlazingStocks Posted - 04/16/24

$NBIO - This announcement comes as the Company prepares for a Phase II trial that follows a very successful Phase I trial-where safety at five ascending dose cohorts was observed-involving 15 patients who received PTB for various types of brain tumors. https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO .10's up now. High of day .1028 on news! https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image BlazingStocks Posted - 04/16/24

$NBIO - announces that it is embarking on a fresh manufacturing run to ensure Pritumumab ("PTB") supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial. https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO Bullish move! 5-day Change +41.16%

User Image UltimateTrader_22 Posted - 04/16/24

$NBIO @MarketWatch #News Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run https://www.marketwatch.com/press-release/nascent-prepares-for-pivotal-phase-ii-research-with-fresh-manufacturing-run-20b3abed?mod=mw_quote_news_seemore

User Image BlazingStocks Posted - 04/16/24

$NBIO News April 16, 2024 Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

User Image StockWorldz Posted - 04/16/24

$NBIO on my radar, loading up this week

User Image Trader008 Posted - 04/12/24

$NBIO The most toxic and short selling market makers PUMA and OTCN bid sitting low 6s...

User Image zabubba Posted - 04/12/24

$NBIO Evil I bought the 16k for you to move the price up I want you to be happier

User Image EvIL_UnICoRn_SlAYeR Posted - 04/12/24

$NBIO Criminal price manipulation. For 4 days within the last 2wks, this security barely traded; like near zero shares. Then a sudden price drop from .18 to .8 as some spread offering rumor despite a proposed. 15 offering price. No finalized S1 issued, yet here we are. Disgraceful stuff! Market manipulation is the intentional and artificial manipulation of supply and demand to influence a stock's price. Manipulators benefit when other investors buy or sell securities whose price has been manipulated. Rumours and fake transactions are used to manipulate the price of securities. Stock market manipulation is the attempt to mislead investors by manipulating the supply and demand of an asset to raise or lower. Something smell rot here.

User Image zabubba Posted - 04/11/24

$NBIO this evil unicorn person seems triggered.. or it’s an AI bot I can’t tell.

User Image EvIL_UnICoRn_SlAYeR Posted - 04/10/24

$NBIO @zabubba LOL, you're right Einstein. They're a lottery until they're not. Instead of bashing, how about you move on since "this isn't your type of thing"? You come a dime a dozen on ST. Making snide comments while dreaming of buying-in at lower price. Gotta give it to you; you seem smarter than the FDA.

User Image Trader008 Posted - 04/10/24

$NBIO Offering could be 0.04 to 0.06. I guess we will find out soon. S1 details are all proposed not official. Would suck to see this below 0.04.

User Image morealpha Posted - 04/09/24

$NBIO warrants are priced at $.05 with 1.25M of them up for grabs while 20M shares are priced at $0.15. Wouldn’t this make you think that they expect it to go up from here?

User Image DollarCoins Posted - 04/09/24

$NBIO Good entry

User Image zabubba Posted - 04/08/24

$NBIO it is and has always been a lotto play

User Image zabubba Posted - 04/08/24

$NBIO only thing that makes this actually go up now is positive phase2 which is probably very unlikely

User Image ok2buy Posted - 04/08/24

$NBIO Sure, you can be mad at yourself. But management has done another $hitty deal and $crewed over existing $hareholders. There is never any regard for current shareholders, that has been consistently demonstrated. I only hope that some of the larger shareholders organize and maybe we see some pressure applied to our current leadership. This is an unmitigated disaster (once again)!/

User Image zabubba Posted - 04/08/24

$NBIO I’m only mad at myself for knowing there was an offering watching the price rise and not selling anything

User Image ok2buy Posted - 04/08/24

$NBIO Not a single long should be happy with management. Nobody is making any money here with our current leadership. These guys continue to bring in deals that erode current share value. From 19 cents to 8! That is truly shameful.//

User Image ok2buy Posted - 04/08/24

$NBIO Another outstanding job by our current management (sarcasm). Recent high of $0.19 taken down to $$0.08 today. You should be congratulated. Why don't you award yourself some cheap shares for all your hard work./

User Image zabubba Posted - 04/08/24

$NBIO going to .05 where warrants are priced

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HOLDEN LOWELL THOMAS CFO CFO Jan 27 Buy 0.14 20,000 2,800 8,418,277 02/02/23
HOLDEN LOWELL THOMAS CFO CFO Jul 21 Sell 0.26 5,000 1,300 8,112,277 07/25/22